Conounding factors in targeted degradation of short-lived proteins

Conounding factors in targeted degradation of short-lived proteins

February 22, 2024 | Vesna Vetma1,2,8, Laura Casarez-Perez1,2,8, Ján Eliaš3,8, Andrea Stingu3, Anju Kombara3, Teresa Gmaschitz3, Nina Braun3, Tuncay Ciftci3, Georg Dahmann3, Emelyne Diers3, Thomas Gerstberger3, Peter Greb3, Giorgia Kidd1,2, Christiane Kofink3, Ilaria Puoti1,2, Valentina Spiteri1,2, Nicole Trainor2, Yvonne Westermaier3, Claire Whitworth2, Alessio Ciulli1,2, William Farnaby1,2, Kirsten McAulay1,2, Aileen B. Frost1,2, Nicola Chessum3 and Manfred Koegl3,4
The article explores the impact of the natural half-life of target proteins on the efficacy of degrader agents in targeted protein degradation (TPD). Using mathematical modeling, the authors demonstrate that the half-life of a target protein significantly affects the level of protein degradation induced by a degrader agent. They find that agents that stall protein synthesis, such as GSPT1 degraders and cytotoxic compounds, can appear as effective protein degraders for short-lived proteins like MCL1 and MDM2. This is exemplified by the disappearance of these proteins upon GSPT1 degradation or treatment with cytotoxic agents like doxorubicin. The study also highlights the limitations of conventional control experiments, such as proteasome inhibition, in differentiating between bona fide degraders and artifacts. The authors propose several control experiments to distinguish true protein degraders from artifacts, including degradation time courses, competition experiments with binders, and analysis of effects on other short-lived proteins. These findings have implications for the selection of targets and the design of control experiments in TPD research.The article explores the impact of the natural half-life of target proteins on the efficacy of degrader agents in targeted protein degradation (TPD). Using mathematical modeling, the authors demonstrate that the half-life of a target protein significantly affects the level of protein degradation induced by a degrader agent. They find that agents that stall protein synthesis, such as GSPT1 degraders and cytotoxic compounds, can appear as effective protein degraders for short-lived proteins like MCL1 and MDM2. This is exemplified by the disappearance of these proteins upon GSPT1 degradation or treatment with cytotoxic agents like doxorubicin. The study also highlights the limitations of conventional control experiments, such as proteasome inhibition, in differentiating between bona fide degraders and artifacts. The authors propose several control experiments to distinguish true protein degraders from artifacts, including degradation time courses, competition experiments with binders, and analysis of effects on other short-lived proteins. These findings have implications for the selection of targets and the design of control experiments in TPD research.
Reach us at info@study.space